96963 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Cytokines; Lymphokines; Interferons; Interleukins [IL] IL-6
MODIFIED GLUCOKINASE NUCLEIC ACIDS FOR TREATING DIABETES
#2REGULATION OF IMMUNE RESPONSES THROUGH SELECTIVE NEURAL ACTIVATION
#3THERAPEUTIC CYTOKINES AND METHODS
#4COMPOSITIONS, SYSTEMS AND METHODS FOR MANIPULATING AREA POSTREMA (AP) NEURONS BASED ON GFRAL SENSING
#5ANTI IL-6 DOMAIN ANTIBODIES WITH FATTY ACID SUBSTITUENTS
#6HUMANIZED IL-6 AND IL-6 RECEPTOR
#7CHIMERIC ANTIGEN RECEPTOR MODIFIED REGULATORY T CELLS FOR TREATING CANCER
#8USE OF VIRAL IL-6 IN CANCER THERAPY
#9TGF-Beta Polypeptides
#10ANTI IL-6 DOMAIN ANTIBODIES
#11ENGINEERED COMPOSITIONS FOR BONE-TARGETED THERAPY
#12DYSREGULATION OF TRAUMA REGULATION PATHWAY TREATMENT AND MONITORING TECHNIQUES
#13Dendritic Cell Generator
#14ENGINEERED SAFETY IN CELL THERAPY
#15EFFECT OF GB1 DOMAIN FUSION ON UPREGULATION OF RECOMBINANT PROTEIN EXPRESSION IN PLANT
#16PROTEIN SIGNATURES FOR DISTINGUISHING BETWEEN BACTERIAL AND VIRAL INFECTIONS
#17CELLULAR POPULATIONS AND USES THEREOF
#18IMMUNOREGULATORY METHOD, NUCLEIC ACID COMPOSITION FOR IMMUNOREGULATION, AND USE THEREOF
#19MODIFIED INSULIN AND GLUCOKINASE NUCLEIC ACIDS FOR TREATING DIABETES
#20CORRECTION OF HEPATOSTEATOSIS IN HUMANIZED LIVER ANIMALS THROUGH RESTORATION OF IL6/IL6R/GP130 SIGNALING IN HUMAN HEPATOCYTES
#21ACTIVATABLE POLYPEPTIDE SEQUENCES FOR PREPARING CYCLIZED POLYPEPTIDES
#22BISPECIFIC BINDING AGENT-LIGAND FUSIONS FOR THE DEGRADATION OF TARGET PROTEINS
#23SYNTHETIC IL6-IL1BETA FUSION CYTOKINE FOR PROMOTING T CELL CYTOTOXIC FUNCTION, T CELL PROLIFERATION, AND TUMORICIDAL ACTIVITY
#24CORRECTION OF HEPATOSTEATOSIS IN HUMANIZED LIVER ANIMALS THROUGH RESTORATION OF IL6/IL6R/GP130 SIGNALING IN HUMAN HEPATOCYTES
#25REGULATION OF IMMUNE RESPONSES THROUGH SELECTIVE NEURAL ACTIVATION
#26HUMAN ANTIBODY SPECIFIC FOR INTERLEUKIN-1ALPHA
#27TGF-Beta Polypeptides
#28ENGINEERED EXTRACELLULAR VESICLES DISPLAYING ENHANCED PHARMACOKINETICS
#29TRANSGENIC MOUSE MODELS SUPPORTING HUMAN INNATE IMMUNE FUNCTION
#30CELLULAR POPULATIONS AND USES THEREOF
#31CELLULOSE BINDING DOMAIN (CBD) CELL EFFECTOR PROTEIN (CEP) CHIMERA, FOR THE TISSUE ENGINEERING
#32ENHANCED-AFFINITY ANTI-ECM NANOBODY-CYTOKINE FUSIONS AND THEIR APPLICATIONS
#33Enhanced Chimeric Antigen Receptor Cells in Hypoxic Tumor Microenvironment
#34ANTIGEN-PRESENTING EXTRACELLULAR VESICLES, COMPOSITION CONTAINING SAME, AND METHOD FOR PRODUCTION THEREOF
#35IMMUNOGENIC CONJUGATE INTENDED TO INDUCE AN IMMUNE RESPONSE DIRECTED AGAINST INTERLEUKIN-6
#36IMMUNOREGULATORY METHOD, NUCLEIC ACID COMPOSITION FOR IMMUNOREGULATION AND USE THEREOF
#37NUCLEIC ACID CONSTRUCT, AND THERAPEUTIC OR DIAGNOSTIC AGENT FOR MISMATCH REPAIR DEFICIENT CANCERS COMPRISING NUCLEIC ACID CONSTRUCT
#38Dendritic cell generator
#39ANAPLASTIC LYMPHOMA KINASE CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE
#40NK CELL-BASED THERAPY
#41TGF-β polypeptides
#42Modified Cell Expressing Therapeutic Agent and Uses thereof
#43Methods of prognosis and treatment
#44SELECTIVE IL-6-TRANS-SIGNALLING INHIBITOR COMPOSITIONS
#45NOVEL IL-10 VARIANT PROTEIN AND USE THEREOF
#46KAPPA MYELOMA ANTIGEN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
#47GENETICALLY MODIFIED IMMUNE CELL, PREPARATION METHOD THEREFOR, AND APPLICATION
#48CYTOKINE COCKTAILS FOR SELECTIVE EXPANSION OF T CELL SUBSETS
#49ADMINISTRATION OF A SELECTIVE IL-6-TRANS-SIGNALLING INHIBITOR
#50Methods, compositions and uses thereof for reversing sarcopenia
#51Modified Cell Expansion and Uses Thereof
#52Humanized IL-6 and IL-6 receptor
#53GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC GENES
#54Protein signatures for distinguishing between bacterial and viral infections
#55Methods and Compositions Relating to p62/SQSTM1 for the Treatment and Prevention of Inflammation-Associated Diseases
#56Modified Cell Expressing Therapeutic Agent and Uses thereof
#57Dysregulation of trauma regulation pathway treatment and monitoring techniques
#58Engineered safety in cell therapy
#59IL-6 gene and detection method of disease-resistant SNP marker thereof
#60HUMAN ANTIBODY SPECIFIC FOR INTERLEUKIN-1ALPHA
#61Generating HPV antigen-specific cells from a naive T cell population
#62Modified Cell Expressing Therapeutic Agent and Uses thereof
#63Generating HPV antigen-specific cells from a naive T cell population
#64NK CELL EXPANSION AND USES THEREOF
#65Genetically modified non-human animals and methods of use thereof
#66Dendritic cell generator
#67MANNOSE-6-PHOSPHATE BEARING PEPTIDES FUSED TO LYSOSOMAL ENZYMES
#68Modified cell expressing therapeutic agent and uses thereof
#69Cellular populations and uses thereof
#70FUNCTION INHIBITOR OF SWI/SNF COMPLEXES
#71Anti-tumor T cells and their preparation using IL-6
#72Selective IL-6-trans-signalling inhibitor compositions
#73Compositions and methods for expansion of embryonic hematopoietic stem cells
#74Ligands Modified by Circular Permutation as Agonists and Antagonists
#75gene and detection method of disease-resistant SNP marker thereof
#76Combination of an anti-CD16A antibody with a cytokine
#77Humanized IL-6 and IL-6 receptor
#78IL6R block CAR-T transgenic vector for alleviating CRS, preparation method thereof
#79Methods of prognosis and treatment
#80CYSTEINE VARIANTS OF INTERLEUKIN-11 AND METHODS OF USE THEREOF
#81Methods and compositions relating to p62/SQSTM1 for the treatment and prevention of inflammation-associated diseases
#82SUPPRESSION OF CANCER
#83Protein signatures for distinguishing between bacterial and viral infections
#84Method for treating rheumatoid arthritis by administering IL-6 receptor antibodies
#85Methods for reducing severity of pulmonary fibrosis
#86METHODS RELATING TO ACTIVATED DENDRITIC CELL COMPOSITIONS AND IMMUNOTHERAPEUTIC TREATMENTS FOR SUBJECTS WITH ADVANCED CANCERS
#87METHODS OF PRODUCING AND PURIFYING MATRIX-BINDING FUSION PROTEINS BY ION-EXCHANGE CHROMATOGRAPHY
#88Generating HPV antigen-specific cells from a naive T cell population
#89Humanized IL-6 and IL-6 receptor
#90Kappa myeloma antigen chimeric antigen receptors and uses thereof
#91Compositions and methods for expansion of embryonic hematopoietic stem cells
#92PEPTIDE FOR PROMOTING CELL MIGRATION AND/OR SKIN WOUND HEALING, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME, AND APPLICATION THEREOF
#93Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#94Dendritic cell generator
#95Human antibody specific for interleukin-1 alpha
#96Genetically modified non-human animals and methods of use thereof
#97Treatment of right ventricular dysfunction due to pressure overload
#98Method to increase the number of circulating platelets by administering PEGylated cysteine variants of IL-11
#99Anti-IL-6 vaccine composition
#100Methods for treatment of inflammatory disease or IL-6-mediated condition with gp130 protein
#101Fusions of antibodies to CD38 and attenuated interferon alpha
#102Mannose-6-phosphate bearing peptides fused to lysosomal enzymes
#103IL-6-binding polypeptide complex
#104Polypeptide
#105Humanized IL-6 and IL-6 receptor
#106Ligands modified by circular permutation as agonists and antagonists
#107Genetically modified non-human animals and methods of use thereof
#108Humanized IL-6 and IL-6 receptor
#109Fusion polypeptides comprising mucin-domain polypeptide linkers
#110METHODS AND COMPOSITIONS FOR CO-EXPRESSION OF POLYPEPTIDES OF INEREST AND IL6
#111Method for producing natively folded proteins in a prokaryotic host
#112Fusion polypeptides comprising an active protein linked to a mucin-domain polypeptide
#113Human antibody specific for interleukin-1alpha
#114Compositions and methods for expansion of embryonic hematopoietic stem cells
#115Humanized IL-6 and IL-6 receptor
#116Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#117Anti-LAMP5 antibody and utilization thereof
#118Human antibody specific for IL-1alpha
#119Repebody for novel interleukin-6 and use thereof
#120Methods for treating rheumatoid arthritis by administering interleukin-6 receptor antibodies
#121Humanized IL-6 and IL-6 receptor
#122Humanized IL-6 and IL-6 receptor
#123Modified SAK gene for the production of recombinant proteins
#124Protein Refolding Method
#125Method for treating chronic colitis and systemic sclerosis and for eliciting a protective immune reaction against human IL-6
#126Suppression of cancer
#127Fusions of antibodies to CD38 and attenuated interferon alpha
#128Ligands modified by circular permutation as agonists and antagonists
#129PROLONGED INHIBITION OF INTERLEUKIN-6 MEDIATED SIGNALING
#130DERIVATIVES OF GROWTH HORMONE AND RELATED PROTEINS
#131Treatment of obesity
#132Genetically modified non-human animals and methods of use thereof
#133Fusion polypeptides comprising an active protein linked to a mucin-domain polypeptide
#134Fusion polypeptides comprising mucin-domain polypeptide linkers
#135Ligands modified by circular permutation as agonists and antagonists
#136Modified SAK gene for the production of recombinant proteins
#137Humanized IL-6 and IL-6 receptor
#138Peptides for active anti-cytokine immunization
#139DIAGNOSTIC METHOD FOR DETECTING CANCER BY MEASURING AMOUNT OF A CYTOKINE LIKE IL-6
#140Method for producing natively folded proteins in a prokaryotic host
#141TH1/TH2 polarizing vaccines
#142Interleukin-1 Alpha Antibodies and Methods of Use
#143DNA Vaccine Comprising IL-6-Encoding DNA Construct and Applications Thereof
#144Peptides for active anti-cytokine immunization
#145Method of Producing Hydroxyalkyl Starch Derivatives
#146Interleukin-1 Alpha Antibodies and Methods of Use
#147Interleukin-1 alpha antibodies and methods of use
#148Interleukin-1α antibodies and methods of use
#149Interleukin-1 alpha antibodies and methods of use
#150Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#151SUPPRESSION OF CANCER
#152Cysteine variants of interferon gamma
#153Methods for the treatment of radiation or chemotherapy-induced tissue damage
#154Peptides for active anti-cytokine immunization
#155Protein refolding method
#156Hydroxyalkyl starch derivatives
#157Antibodies to interleukin-6
#158USE OF A CYTOKINE FROM THE INTERLEUKIN-6 FAMILY IN THE PREPARATION OF A COMPOSITION FOR COMBINED ADMINISTRATION WITH INTERFERON-ALPHA
#159Method of Producing Hydroxyalkyl Starch Derivatives
#160COMPOSITIONS COMPRISING MODULATORS OF SIGNAL TRANSDUCING RECEPTOR gp130 AND METHODS OF PRODUCING AND USING SAME
#161Compositions and methods for fusion protein separation
#162Methods of inhibiting photoreceptor apoptosis
#163TREATMENT OF OBESITY
#164Polynucleotide encoding IL-6 receptor/IL-6 fusion protein
#165Peptides for active anti-cytokine immunization
#166CONJUGATE FOR THE SPECIFIC TARGETING OF ANTICANCER AGENTS TO TUMOR CELLS OR TUMOR VASCULATURE AND PRODUCTION THEREOF
#167Interleukin-1α antibodies
#168IL-6/IL-6R Fusion Protein
#169DNA vaccine comprising IL-6-encoding DNA construct and applications thereof
#170Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#171Treatment of hepatitis C with compositions comprising oncostatin M and interferon alpha
#172Methods for attenuating virus strains for diagnostic and therapeutic uses
#173Diagnostic method for detecting cancer by measuring amount of cytokine like IL-6
#174DERIVATIVES OF GROWTH HORMONE AND RELATED PROTEINS
#175Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#176Cysteine variants of interferon gamma
#177Peptides for active anti-cytokine immunization
#178Cysteine variants of interferon-gamma
#179Compositions and methods for therapy or prevention of chemotherapy-induced neuropathy
#180Compositions and methods for fusion protein separation
#181Conjugate for the specific targeting of anticancer agents to tumor cells or tumor vasculature and production thereof
#182Selective Killing Of Cancer Cells By Induction Of Acetyltransferase Via Tnf-Alpha And Il-6
#183Methods of treating cancer comprising administering an interleukin-6 antibody variable region
#184IL-6/IL-6R fusion protein
#185Nucleic acids encoding chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof
#186Method for the purification of a non-immunoglobulin protein comprising an immunoglobulin-like (Ig-like) domain
#187IL-6 receptor•IL-6 direct fusion protein
#188Compositions and methods for fusion protein separation
#189Peptides for active anti-cytokine immunization
#190Method for improving recovery yield in protein purification with gel filtration chromatography
#191Hasylated polypeptides
#192Method of producing hydroxyalkyl starch derivatives
#193Hydroxyalkyl starch derivatives
#194Cysteine substitution variants of beta interferon
#195COOH-terminally added cysteine variant of the beta interferon
#196Complex immuno-gene medical composition for inhibiting tumor cells
#197Chemically modified cytokines
#198Proteins with IL-6 inhibiting activity
#199Use of IL-6-type cytokines for maturation of oocytes
#200Cysteine variants of erythropoietin
#201Cysteine variants of erythropoietin
#202Fusion protein
#203Conjugate for the specific targeting of anticancer agents to cancer cells and production thereof